David S. Newcombe
- Co-authors
- Carl P. CiosekYoshinori IshikawaJohn V. FaheyJoseph ChangAli M. SabooriAlan S. CohenDavid M. LangGlenn A. Warr
- Topics
- Inflammatory mediators and NSAID effects (10 papers)Gout, Hyperuricemia, Uric Acid (9 papers)Biochemical and Molecular Research (6 papers)
- Cited by
- PharmacologyNephrologyBiochemistry
- Partner nations
- United States
In The Last Decade
David S. Newcombe
41 papers receiving 768 citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 287
- Pharmacology 191
- Epidemiology 113
- Immunology 93
- Physiology 88
Countries citing papers authored by David S. Newcombe
This map shows the geographic impact of David S. Newcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Newcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Newcombe more than expected).
Fields of papers citing papers by David S. Newcombe
This network shows the impact of papers produced by David S. Newcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Newcombe. The network helps show where David S. Newcombe may publish in the future.
Co-authorship network of co-authors of David S. Newcombe
This figure shows the co-authorship network connecting the top 25 collaborators of David S. Newcombe. A scholar is included among the top collaborators of David S. Newcombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Newcombe. David S. Newcombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 54 | |
| 3 | 20 | |
| 4 | 14 | |
| 5 | 47 | |
| 6 | 7 | |
| 7 | 46 | |
| 8 | 7 | |
| 9 | 24 | |
| 10 | Inherited biochemical disorders and uric acid metabolism | 5 |
| 11 | 59 | |
| 12 | 6 | |
| 13 | 31 | |
| 14 | 16 | |
| 15 | 17 | |
| 16 | 10 | |
| 17 | 3 | |
| 18 | 4 | |
| 19 | 43 | |
| 20 | 20 |
About David S. Newcombe
David S. Newcombe is a scholar working on Nephrology, Pharmacology and Clinical Biochemistry, having authored 41 papers that have together received 879 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Gout, Hyperuricemia, Uric Acid (9 papers) and Biochemical and Molecular Research (6 papers). The work is most often cited by research in Pharmacology (191 citations), Nephrology (70 citations) and Biochemistry (70 citations). David S. Newcombe has collaborated with scholars based in United States. Frequent co-authors include Carl P. Ciosek, Yoshinori Ishikawa, John V. Fahey, Joseph Chang, Ali M. Saboori, Alan S. Cohen, David M. Lang, Glenn A. Warr, Ahmed H. Esa and Michel Laviolette. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.